Table 1.
Day 3 | Observations | Severity grade | Saline | EXP 9 mg/kg | EXP 18 mg/kg | EXP 30 mg/kg | Bsol 9 mg/kg |
---|---|---|---|---|---|---|---|
Brachial plexus, distal |
Hemorrhage | minimal | 0 | 0 | 1 | 0 | 1 |
moderate | 0 | 1 | 1 | 0 | 0 | ||
Inflammation, granulomatous | minimal | 0 | 3 | 1 | 1 | 0 | |
Inflammation, subacute | minimal | 0 | 0 | 0 | 0 | 1 | |
| |||||||
Brachial plexus, middle | Hemorrhage | minimal | 0 | 2 | 0 | 1 | 0 |
moderate | 0 | 1 | 0 | 0 | 0 | ||
Inflammation, granulomatous | minimal | 0 | 1 | 1 | 3 | 0 | |
Inflammation, subacute | minimal | 0 | 0 | 1 | 0 | 0 | |
| |||||||
Brachial plexus, proximal | Hemorrhage | minimal | 0 | 0 | 1 | 1 | 0 |
mild | 0 | 1 | 0 | 0 | 0 | ||
moderate | 0 | 1 | 0 | 0 | 0 | ||
Inflammation, granulomatous | minimal | 0 | 0 | 1 | 1 | 0 | |
Inflammation, subacute | minimal | 0 | 1 | 1 | 0 | 0 | |
| |||||||
Day 15 | |||||||
| |||||||
Brachial plexus, distal |
Hemorrhage | minimal | 0 | 1 | 1 | 0 | 0 |
mild | 0 | 0 | 1 | 1 | 0 | ||
moderate | 0 | 0 | 0 | 1 | 0 | ||
Inflammation, subacute | minimal | 0 | 1 | 0 | 0 | 0 | |
| |||||||
Brachial plexus, middle | Fibrosis | minimal | 0 | 0 | 0 | 0 | 1 |
Hemorrhage | minimal | 0 | 1 | 1 | 0 | 2 | |
mild | 0 | 0 | 0 | 0 | 1 | ||
Inflammation, granulomatous | mild | 0 | 0 | 1 | 0 | 0 | |
Inflammation subacute | minimal | 0 | 1 | 0 | 0 | 0 | |
Mineralization | minimal | 0 | 0 | 1 | 0 | 0 | |
| |||||||
Brachial plexus, proximal | Hemorrhage | minimal | 0 | 2 | 0 | 0 | 0 |
mild | 0 | 1 | 1 | 1 | 0 | ||
moderate | 0 | 0 | 0 | 0 | 1 |
EXP, EXPAREL (bupivacaine liposome injectable suspension); Bsol, bupivacaine solution.
Note: number of animals examined was 4/group on Day 3 or Day 15.